ClinVar Miner

Submissions for variant NM_152281.3(GORAB):c.1A>G (p.Met1Val)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Neuberg Centre For Genomic Medicine, NCGM RCV005208320 SCV005849310 likely pathogenic Geroderma osteodysplastica criteria provided, single submitter clinical testing The start lost c.1A>G (p.Met1?) variant in GORAB The start lost c.1A>G (p.Met1?) variant in GORAB gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is present with allele frequency of 0.003% in gnomAD Genomes. This variant has not been submitted to the ClinVar database. Multiple lines of computational evidence (Polyphen - Probably Damaging, SIFT - Damaging and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. The reference amino acid at this position on GORAB is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The p.Met1? variant is predicted to disrupt the initiation codon, and thus potentially may interfere with protein expression. However, additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic.has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is present with allele frequency of 0.003% in gnomAD Genomes. This variant has not been submitted to the ClinVar database. Multiple lines of computational evidence (Polyphen - Probably Damaging, SIFT - Damaging and MutationTaster - Disease causing) predict a damaging effect on protein structure and function for this variant. The reference amino acid at this position on GORAB is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. The p.Met1? variant is predicted to disrupt the initiation codon, and thus potentially may interfere with protein expression. However, additional functional studies will be required to prove the pathogenicity of this variant. For these reasons, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.